Case study
The demo became the distributor.
A pitch site for an overseas peptide manufacturer, built at their table in Guangzhou in September 2026, is now a working US desk with BizNomad as distributor of record.
A pitch site for an overseas peptide manufacturer, built at their table in Guangzhou in September 2026, is now a working US desk with BizNomad as distributor of record.
US research buyers pick the supplier who answers first with a COA already attached. A factory twelve hours ahead of Atlanta loses that race every day, and its English-language inbound is noisy: a large share of messages come from individuals or clinics the factory cannot legally serve. Sorting them costs staff time and creates risk.
We had already shown them the fix as a pitch. The obvious next step was to run it ourselves.
The factory price list is parsed into a research-neutral catalog. Consumer-injectable items are excluded. Buyers see compounds, sizes and available documentation, never cost.
Organisation type, business email, research application and a signed attestation are required. Clinics, med-spas, compounders and personal use are declined automatically, as is any request that references human use.
Each qualified request is summarised in Chinese for the factory and flagged for risk. The owner gets a phone notification with the buyer, the items and one-tap links to the quote.
The owner view shows factory cost per line, the invoice figure at the chosen spread, and the margin. Invoicing is by wire or ACH; the factory ships with the COA, HPLC and MS on the lot.
The voice line and the message agent from the original pitch feed the same qualification, so a buyer can call, message or click and get the same answer.
This is the BizNomad model. The manufacturer paid nothing up front. We earn when they earn. Every quote, every declined request and every document sent is logged, so this case study updates itself.